[Interpretation of 2020 NCCN Clinical Practice Guidelines in Oncology-Bone Cancer]

Zhonghua Wai Ke Za Zhi. 2020 Jun 1;58(6):430-434. doi: 10.3760/cma.j.cn112139-20200204-00061.
[Article in Chinese]


The specialty of bone cancer has developed rapidly in China in recent years, but because of the low incidence of these diseases and the unbalanced development of different regions, the malpractice problem of diagnosis and treatment is still outstanding.The NCCN clinical practice guide for bone cancer in the United States has been updated for several years and is now more mature and has been recognized worldwide.It can provide reference for medical professionals in related fields in China, it covers the most common bone tumors such as osteosarcoma, Ewing's sarcoma, chondrosarcoma, giant cell tumor of bone and chordoma.This article describes and interprets the core diagnostic and therapeutic contents of NCCN clinical practice guide for bone cancers.


Keywords: Bone neoplasms; Guideline books; Interpretation.

MeSH terms

  • Bone Neoplasms / diagnosis*
  • Bone Neoplasms / therapy*
  • China
  • Chordoma / diagnosis
  • Chordoma / therapy
  • Giant Cell Tumor of Bone / diagnosis
  • Giant Cell Tumor of Bone / therapy
  • Humans
  • Practice Guidelines as Topic / standards*
  • Sarcoma / diagnosis
  • Sarcoma / therapy
  • United States